All News

ViiV Healthcare reports long-term positive results for its drug, Rukobia (fostemsavir).

The harm caused by weight-loss drugs have overwhelmed any benefit they may have. The repurposed diabetes drugs like Wegovy (semaglutide) have a strong safety profile.

Your weekly roundup of the latest news from Drug Topics®.

Your weekly roundup of the latest news from Drug Topics®.

Your weekly roundup of the latest news from Drug Topics®.

Survey participants said their drug costs have gone up and almost a third had trouble paying for food and housing because of high drug costs.

This recall of propofol because of particulates seen in vials follows a previous one in July 2022.

Take a look back at our most popular news from August 2022.

Medicare users will see prescription drug pricing reform thanks to the Inflation Reduction Act.

Nonsteroidal topical agents and TYK2 inhibitors may join an already full armamentarium.

Drug manufacturers are rejecting the program’s blanket discounts involving contract pharmacies. A flurry of litigation has ensued.

Consumers are purchasing dietary supplements that support or boost the immune system like never before.

Opioid use disorder—how can we battle the epidemic of overdoses?

Your weekly roundup of the latest news from Drug Topics®.

Examining the results of a study examining the role of supplements and diets in managing psoriasis.

Overall numbers may be lower, but the obese, racial/ethnic minorities, and those without health care access have higher numbers of undiagnosed diabetes

The rule change could save money for millions.

Patients are either skipping care completely, cutting costs elsewhere, or borrowing money to pay for health care

Your weekly roundup of the latest news from Drug Topics®.

Oteseconazole is a treatment option for those living with a previously unmet medical need.

Your weekly roundup of the latest news from Drug Topics®.

More people getting health coverage, but 26.4 million still don’t have it.

A new CE opportunity that's available on-demand.

Arcutis Biotherapeutics’ roflumilast cream will provide relief to patients aged 12 years or older diagnosed with plaque psoriasis.

A joint statement from the two Democrats senators says prescription drug reform would save the federal government $288 billion over the next 10 years.

Your weekly roundup of the latest news from Drug Topics®.

Take a look back at our most popular news from July 2022.

New research adds more evidence against the supplement's efficacy in preventing fractures.